Hypoxia-Inducible Factors in Liver Metabolism

肝脏代谢中的缺氧诱导因素

基本信息

  • 批准号:
    8446375
  • 负责人:
  • 金额:
    $ 32.12万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-04-20 至 2015-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Nonalcoholic fatty liver disease (NAFLD) occurs in patients without significant alcohol consumption and represents a clinico-histopathological entity with histological features that resemble alcohol-induced liver injury. We have used conditional gene targeting in hepatocytes to inactivate the pVHL-E3-ubiquitin ligase, which targets Hypoxia-Inducible-Factor (HIF) for degradation under normoxia. We have discovered that increased HIF activity alters fatty acid metabolism and results in the development of non-alcoholic fatty liver disease in mice. Hypoxia-Inducible Factor-1 and -2 (HIF-1 and HIF-2) are heterodimeric basic-loop-helix transcription factors and are key mediators of cellular adaptation to diminished oxygen supply. Our findings implicate HIF signaling, in particular signaling through HIF-2, in the development of fatty liver disease. In this grant application we propose in vivo and in vitro studies that make use of conditional gene targeting technology and transgenesis to investigate the role of HIF signaling in the regulation of fatty acid uptake, synthesis, beta-oxidation and secretion. Additional in vitro studies are proposed that specifically focus on selected HIF target genes to study their role in lipid metabolism under hypoxia. In Aim 1 we carry out functional studies in VHL mutant mice, in Aim 2 we investigate the role of HIF activation early in the development of steatosis following acute inactivation of pVHL in the adult, and Aims 3 and 4 investigate the role of HIF-2 in a wild type genetic background with a focus on HIF-2 target genes relevant for the development of steatosis. The proposed studies are not only important for our understanding of basic HIF functions in lipid metabolism, but more importantly have direct clinical relevance. We provide a direct molecular link between hypoxic injury and fatty liver development and establish a novel role for the HIF pathway in the pathogenesis of NAFLD.
描述(由申请方提供):非酒精性脂肪性肝病(NAFLD)发生在无显著饮酒的患者中,代表一种临床组织病理学实体,其组织学特征类似于酒精诱导的肝损伤。我们已经在肝细胞中使用了条件性基因靶向来抑制pVHL-E3-泛素连接酶,其靶向低氧诱导因子(HIF)以在常氧下降解。我们已经发现,增加HIF活性改变脂肪酸代谢,并导致小鼠非酒精性脂肪肝疾病的发展。缺氧诱导因子-1和-2(HIF-1和HIF-2)是异源二聚体碱性环螺旋转录因子,并且是细胞适应减少的氧供应的关键介质。我们的研究结果暗示HIF信号,特别是通过HIF-2的信号,在脂肪肝疾病的发展。在这项资助申请中,我们提出了体内和体外研究,利用条件基因靶向技术和转基因研究HIF信号在调节脂肪酸摄取,合成,β-氧化和分泌中的作用。提出了额外的体外研究,特别关注选定的HIF靶基因,以研究它们在缺氧条件下的脂质代谢中的作用。在目的1中,我们在VHL突变小鼠中进行功能研究,在目的2中,我们研究了HIF激活在成人pVHL急性失活后脂肪变性发展早期的作用,目的3和4研究了HIF-2在野生型遗传背景中的作用,重点是与脂肪变性发展相关的HIF-2靶基因。所提出的研究不仅对我们理解HIF在脂质代谢中的基本功能很重要,更重要的是具有直接的临床相关性。我们提供了缺氧损伤和脂肪肝发展之间的直接分子联系,并建立了HIF通路在NAFLD发病机制中的新作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Volker Hans Haase其他文献

Volker Hans Haase的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Volker Hans Haase', 18)}}的其他基金

Mitochondrial electron transport dysfunction: Dissecting pathomechanisms
线粒体电子传递功能障碍:剖析病理机制
  • 批准号:
    10679988
  • 财政年份:
    2023
  • 资助金额:
    $ 32.12万
  • 项目类别:
Metabolic Reprogramming in Acute Kidney Injury
急性肾损伤中的代谢重编程
  • 批准号:
    8930970
  • 财政年份:
    2014
  • 资助金额:
    $ 32.12万
  • 项目类别:
Metabolic Reprogramming in Acute Kidney Injury
急性肾损伤中的代谢重编程
  • 批准号:
    9100699
  • 财政年份:
    2014
  • 资助金额:
    $ 32.12万
  • 项目类别:
Metabolic Reprogramming in Acute Kidney Injury
急性肾损伤中的代谢重编程
  • 批准号:
    8816559
  • 财政年份:
    2014
  • 资助金额:
    $ 32.12万
  • 项目类别:
Cellular and Molecular Mechanisms of Renal Anemia
肾性贫血的细胞和分子机制
  • 批准号:
    8966671
  • 财政年份:
    2013
  • 资助金额:
    $ 32.12万
  • 项目类别:
Cellular and Molecular Mechanisms of Renal Anemia
肾性贫血的细胞和分子机制
  • 批准号:
    10587989
  • 财政年份:
    2013
  • 资助金额:
    $ 32.12万
  • 项目类别:
Cellular and Molecular Mechanisms of Renal Anemia
肾性贫血的细胞和分子机制
  • 批准号:
    10427228
  • 财政年份:
    2013
  • 资助金额:
    $ 32.12万
  • 项目类别:
Cellular and Molecular Mechanisms of Renal Anemia
肾性贫血的细胞和分子机制
  • 批准号:
    9275414
  • 财政年份:
    2013
  • 资助金额:
    $ 32.12万
  • 项目类别:
Cellular and Molecular Mechanisms of Renal Anemia
肾性贫血的细胞和分子机制
  • 批准号:
    8633776
  • 财政年份:
    2013
  • 资助金额:
    $ 32.12万
  • 项目类别:
Cellular and Molecular Mechanisms of Renal Anemia
肾性贫血的细胞和分子机制
  • 批准号:
    10265319
  • 财政年份:
    2013
  • 资助金额:
    $ 32.12万
  • 项目类别:

相似海外基金

cGAS-STING Pathway Targeting Replicative Adenoviruses with CD46 Tropism and AFP Promoter Conditional Replication Restriction for the Treatment of Hepatocellular Carcinoma
cGAS-STING 通路靶向具有 CD46 趋向性和 AFP 启动子的复制腺病毒条件性复制限制用于治疗肝细胞癌
  • 批准号:
    10436626
  • 财政年份:
    2021
  • 资助金额:
    $ 32.12万
  • 项目类别:
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
  • 批准号:
    10557162
  • 财政年份:
    2021
  • 资助金额:
    $ 32.12万
  • 项目类别:
Molecular therapy of replication-competent adenoviruses targeting characteristic gene mutations found in mesothelioma
针对间皮瘤中发现的特征基因突变的具有复制能力的腺病毒的分子疗法
  • 批准号:
    21K08199
  • 财政年份:
    2021
  • 资助金额:
    $ 32.12万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
  • 批准号:
    10330464
  • 财政年份:
    2021
  • 资助金额:
    $ 32.12万
  • 项目类别:
Structural characterization of nucleoprotein cores of human adenoviruses
人腺病毒核蛋白核心的结构表征
  • 批准号:
    9807741
  • 财政年份:
    2019
  • 资助金额:
    $ 32.12万
  • 项目类别:
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
  • 批准号:
    41625-2013
  • 财政年份:
    2018
  • 资助金额:
    $ 32.12万
  • 项目类别:
    Discovery Grants Program - Individual
The therapeutic strategies with augmented replications of oncolytic adenoviruses for malignant mesothelioma
溶瘤腺病毒增强复制治疗恶性间皮瘤的治疗策略
  • 批准号:
    18K15937
  • 财政年份:
    2018
  • 资助金额:
    $ 32.12万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
  • 批准号:
    41625-2013
  • 财政年份:
    2017
  • 资助金额:
    $ 32.12万
  • 项目类别:
    Discovery Grants Program - Individual
Exploring the effects of nutrient deprivation on T cells and oncolytic adenoviruses, in order to create immune activators for tumour therapy
探索营养剥夺对 T 细胞和溶瘤腺病毒的影响,以创造用于肿瘤治疗的免疫激活剂
  • 批准号:
    1813152
  • 财政年份:
    2016
  • 资助金额:
    $ 32.12万
  • 项目类别:
    Studentship
Research on detection of novel adenoviruses by genetic methods
新型腺病毒的基因检测研究
  • 批准号:
    16K09118
  • 财政年份:
    2016
  • 资助金额:
    $ 32.12万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了